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CARPAL TUNNEL SYNDROME(CTS) is the most commonentrapment neuropathy and iscaused by compression of the
median nerve at the wrist. The preva-
lence of electrophysiologically con-
firmed CTS in the adult general popu-
lation in the Netherlands is 0.6% in men
and 9.2% in women.1 While CTS may
be treated with conservative options
such as wrist splints, injections with cor-
ticosteroids, or both, evidence for the ef-
ficacy of most conservative treatment op-
tions is limited.2 A recent systematic
review has shown that among the vari-
ous available surgical techniques, open
carpal tunnel release is the preferred
method.3 However, only 1 randomized
controlled trial (RCT) has compared
conservative treatment (splinting) with
surgery,4 but provided no information
on comparability of the groups at base-
line, cointerventions, compliance with
the treatment, or blinding of the out-
come assessor. Furthermore, only 1 fol-
low-up assessment was performed af-
ter 1 year, showing that the 10 patients
treated surgically had complete relief of
symptoms while 2 of the 10 patients
treated with a wrist splint had experi-
enced relief only temporarily.
Due to limited evidence, there is no
consensus on the preferred method of
treatment for CTS. Advocates of sur-
gery refer to its safety and effectiveness
for electrophysiologically confirmed
cases with no underlying reversible dis-
order,5 and point out that conservative
treatment options generally offer only
temporary symptom relief. Advocates of
conservative options refer to the poten-
tial benefits and safety of these treat-
ments and to the potential complica-
tionsof surgery.6 In theNetherlands,40%
of theneurologists reported toprefer con-
servative treatment options, 39% re-
ported to prefer surgery, and 21% re-
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Context Carpal tunnel syndrome (CTS) can be treated with nonsurgical or surgical
options. However, there is no consensus on the most effective method of treatment.
Objective To compare the short-term and long-term efficacy of splinting and sur-
gery for relieving the symptoms of CTS.
Design, Setting, and Patients A randomized controlled trial conducted from Oc-
tober 1998 to April 2000 at 13 neurological outpatient clinics in the Netherlands. A
total of 176 patients with clinically and electrophysiologically confirmed idiopathic CTS
were assigned to wrist splinting during the night for at least 6 weeks (89 patients) or
open carpal tunnel release (87 patients); 147 patients (84%) completed the final fol-
low-up assessment 18 months after randomization.
Main Outcome Measures General improvement, number of nights waking up due
to symptoms, and severity of symptoms.
Results In the intention-to-treat analyses, surgery was more effective than splinting
on all outcome measures. The success rates (based on general improvement) after 3
months were 80% for the surgery group (62/78 patients) vs 54% for the splinting
group (46/86 patients), which is a difference of 26% (95% confidence interval [CI],
12%-40%; P.001). After 18 months, the success rates increased to 90% for the sur-
gery group (61/68 patients) vs 75% for the splinting group (59/79 patients), which is
a difference of 15% (95% CI, 3%-27%; P=.02). However, by that time 41% of pa-
tients (32/79) in the splint group had also received the surgery treatment.
Conclusion Treatment with open carpal tunnel release surgery resulted in better out-
comes than treatment with wrist splinting for patients with CTS.
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ported to have no preference.7 Splinting
was the preferred treatment of 26% of the
neurologists and is the most common.
The objective of this study was to com-
pare the short-term and long-term effi-
cacy of splinting and surgery for reliev-
ing the symptoms of CTS.
METHODS
The medical ethics committees of the 13
participating hospitals approved the
study protocol of this multicenter RCT.
Adetaileddescriptionof thedesignof this
RCT has been previously published.8
Study Population
All patients with clinically suspected CTS
had been referred to one of the partici-
pating neurologists and were examined
for eligibility to participate in the study.
Inclusion criteria were (1) pain, pares-
thesia, and/or hypoesthesia in the hand
in the area innervated by the median
nerve9; (2) electrophysiological confir-
mation of the diagnosis8 (median nerve
sensory conduction velocity of the in-
dex finger 41.9 m/s in patients 55
years or37.3 m/s in patients55 years,
or median nerve distal sensory latency
of the index finger3.5 ms; or median-
ulnar distal sensory latency difference of
the ring finger0.4 ms; or median nerve
distal motor latency4.34 ms); (3) age
of 18 years or older; and (4) ability to
complete written questionnaires (in
Dutch). Exclusion criteria were (1) pre-
vious treatment with splinting or sur-
gery; (2) a history of wrist trauma (eg,
fracture) or surgery; (3) a history sug-
gesting underlying causes of CTS (eg,
diabetes mellitus, pregnancy); (4) clini-
cal signs or symptoms or electrophysi-
ological findings suggesting conditions
that could mimic CTS or interfere with
its validation (eg, cervical radiculopa-
thy, polyneuropathy); and (5) severe the-
nar muscle atrophy.
Patients, who were eligible according
to their neurologist and were interested
in participation, were referred to one of
the research physiotherapists in the same
hospital, who verified that all selection
criteria were met. After they had pro-
vided written informed consent, pa-
tients were included in the study. Sub-
sequently,potentialprognostic indicators
and the baseline values of the outcome
measures were assessed.
Treatment Allocation
Patients were randomly allocated to
receive either splinting or surgery
(FIGURE 1). If bilateral symptoms were
present, the hand with the more severe
symptoms (according to the patient) was
treated. By preparing a list for each hos-
pital, the randomization was stratified by
center. Permuted blocks of 4 patients
were formed to ensure near-equal dis-
tribution of patients over the 2 treat-
ment groups in each hospital.10 Despite
the small block sizes, the potential for un-
masking was considered to be low be-
cause the neurologists did not know the
method of randomization and different
neurologists selected patients in each
hospital. Even if a neurologist were to
know the allocation scheme, the chance
was high that when he/she selected a pa-
tient, this patient would not be as-
signed the next treatment on the list be-
cause a patient selected by another
neurologist has an earlier appointment
for the trial. The random sequence of the
permuted blocks was generated by us-
ing random number tables. The princi-
pal investigator (A.A.M.G.), who was not
involved in the selection and allocation
of patients, prepared, coded, and sealed
opaque envelopes containing the treat-
ment allocation.11 After the baseline as-
sessment, the next envelope was handed
to the patient by the research assistant
to ensure concealment of allocation.
Blinding
Attempts were made to keep the re-
search physiotherapists unaware of the
allocated treatment by encouraging the
patients not to reveal any information
regarding their treatment during the ex-
amination. Furthermore, before each
examination, the research assistant
placed a bandage over the wrist and
palm of all patients to conceal the po-
tential surgical scar. Afterward, the re-
search physiotherapists were asked to
indicate the type of treatment that they
thought the patient had received and
to give reasons for this assumption.12
Treatment
Depending on the usual procedures of
the hospital, patients allocated to splint-
ing received either a custom-made
splint (made of soft cast) or a prefab-
ricated splint (Tricodur, BSN Medical,
Hamburg, Germany) that immobi-
lized the wrist in a neutral position.13
The patients were instructed to wear the
splint during the night for at least 6
weeks, but could wear it during the day.
No other types of treatment were per-
mitted during the intervention pe-
riod, except pain medication if neces-
sary. After 6 weeks, the neurologist
discussed with the patient whether any
further treatment was necessary, in-
cluding continued splinting, other con-
servative treatment options, or sur-
gery. The decision to undergo surgery
could also be made at a later stage.
Patients allocated to surgery were re-
ferred to a general surgeon, neurosur-
geon, plastic surgeon, or orthopedic sur-
geon, depending on the usual procedures
of the hospital for an outpatient stan-
dard open carpal tunnel release. Be-
cause there are waiting lists for surgery
in hospitals, efforts were made to make
an appointment within 4 weeks after ran-
domization. Before surgery, no other
types of treatment were permitted, ex-
ceptpainmedication. Inall surgical cases,
the transverse carpal ligament was re-
leased and no concomitant procedures
were performed (eg, flexor tenosyno-
vectomy, internal neurolysis, epineu-
rotomy). Sutures were removed after 2
weeks. Patients were instructed to per-
form postoperative active range-of-
motion exercises and encouraged to use
the hand as tolerated. None of the pa-
tients received a splint following the sur-
gical procedure. No specific period off
work was recommended.
Outcome Assessment
Patients completed questionnaires and
were examined by a trained research
physiotherapist in the hospital at base-
line and 3, 6, and 12 months after ran-
domization. Although different re-
search physiotherapists assessed the
outcomes, most patients were seen by
the same therapist each time they vis-
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ited the hospital. In the remaining
months, and 18 months after random-
ization, questionnaires were mailed.
General improvement was scored by
the patient on a 6-point ordinal tran-
sition scale, ranging from “completely
recovered” to “much worse.”12 Treat-
ment success was defined a priori as
“completely recovered” or “much im-
proved.” The 2 other outcome mea-
sures were number of nights that the
patient awoke due to the symptoms
during the past week and severity of the
main complaint, pain, paresthesia, or
hypoesthesia at night and during the
day during the past week. Severity of
the main complaint, pain, paresthesia,
and hypoesthesia were scored by the pa-
tient on an 11-point numerical rating
scale (with 0 equaling “no symptoms”
and 10 equaling “very severe symp-
toms” used as anchors).12
There were 3 secondary outcome
measures used. Mean (SD) scores were
collected using the Symptom Severity
Scale (11 questions about symptoms ex-
perienced during the past 2 weeks with
1 equaling mildest and 5 equaling most
severe) and the Functional Status Scale
(8 items concerning difficulties in per-
forming various activities of daily liv-
ing during the past 2 weeks with 1
equaling no difficulty and 5 equaling
cannot perform activity at all).14 After
a standardized history-taking and a
physical examination, the overall se-
verity of CTS complaints was scored by
a research physiotherapist on an 11-
point numerical rating scale with zero
equaling no complaints and 10 equal-
ing very severe complaints.12 Results of
nerve conduction studies after 12
months were also used. At each fol-
low-up assessment, the patients were
asked to record any treatment they had
received and any adverse effects.
Statistical Analysis
The groups were primarily compared
at 3, 6, and 12 months because all out-
comes were assessed during the visits
at the hospital. Furthermore, to ob-
tain a clear picture of the short-term ef-
fects, the follow-up assessment time of
1 month was chosen. To determine the
long-term effects, the assessment time
of 18 months after randomization was
chosen. Differences in success rates be-
tween the treatment groups along with
95% confidence intervals were calcu-
lated using 2 tests. Continuous out-
comes were analyzed as change scores
(difference between baseline assess-
ment and each follow-up assessment).
Subsequently, differences in improve-
ment between the groups (mean change
score in surgery group minus mean
change score in splint group) along with
95% confidence intervals were calcu-
lated using t tests. Multivariate analy-
ses (logistic or linear regression) were
performed to adjust for the influence
of eventual differences between the
groups at baseline in prognostic indi-
cators (age, sex, duration of current epi-
sode of CTS complaints, bilateral CTS
complaints, dominant side more se-
verely affected, previous episodes of
CTS complaints, and patients’ prefer-
ence for splinting or surgery).
All analyses were performed accord-
ing to the following intention-to-treat
principle: the patients remained in the
group to which they were allocated at
baseline.15 Two additional analyses were
Figure 1. Progress of Patients Through Carpal Tunnel Syndrome (CTS) Trial
326 Patients Examined for Eligibility by Neurologist
215 Examined for Eligibility by Research Physiotherapist
39 Not Eligible
72 Refused Participation
5 No Electrophysiologically Confirmed CTS
9 Language Barrier
8 Prior Splint Treatment
4 Previous Wrist Trauma or Surgery
10 Underlying Causes of CTS
2 Polyneuropathy
1 Severe Thenar Muscle Atrophy
23 Strongly Preferred Splinting
39 Strongly Preferred Surgery
10 Other
176 Randomized
89 Assigned to Receive Splinting
13 Did Not Receive Splinting According
to Protocol as Assigned
10 Withdrawals
3 Lack of Time
1 Not Satisfied With Treatment Result
1 Unable to Go to Hospital at 12 mo
4 Did Not Return Final Questionnaire
1 Other
Follow-up and No. Included in Analyses
88 at 1 mo
86 at 3 mo
84 at 6 mo
83 at 12 mo
79 at 18 mo
87 Assigned to Receive Surgery
14 Did Not Receive Surgery as Assigned
19 Withdrawals
8 Refused Surgery
2 Unable to Go to Hospital at 12 mo
1 Death (Cancer)
1 Lack of Time
5 Did Not Return Final Questionnaire
2 Other
Follow-up and No. Included in Analyses
80 at 1 mo
78 at 3 mo
77 at 6 mo
73 at 12 mo
68 at 18 mo
23 Not Eligible
16 Refused Participation
1 No Electrophysiologically Confirmed CTS
1 Language Barrier
4 Prior Splint Treatment
6 Previous Wrist Trauma or Surgery
10 Underlying Causes of CTS
1 Severe Thenar Muscle Atrophy
8 Strongly Preferred Splinting
6 Strongly Preferred Surgery
2 Other
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performed. In the first analysis, pa-
tients who received surgery after splint-
ing were considered to be not im-
proved. In the second analysis, patients
in the splint group who had received
surgery were compared with patients
in the same group who had not. All pa-
tients who withdrew from the study
were included in the analysis until the
time of withdrawal. For patients who
occasionally missed a follow-up assess-
ment, the available data from com-
pleted assessments were included.
Sample-size calculation was based on
the ability to detect a clinically impor-
tant difference in success rates of 20% or
more 3 months after randomization. A
total sample size of 190 patients was re-
quired (2-sided =.05, =.20). Values
ofP.05wereconsideredstatistically sig-
nificant. Data were analyzed using SPSS
statistical software (Version 10.1; SPSS
Inc, Chicago Ill).
RESULTS
Study Population
During a period of 18 months (Octo-
ber 1998 to April 2000), 326 patients
were examined for eligibility by the neu-
rologists. There were 111 patients who
were either ineligible or not interested
in participation (Figure 1). The remain-
ing 215 patients were referred to one of
the research physiotherapists who veri-
fied that all selection criteria were met.
Of these patients, 39 were not random-
ized for various reasons (Figure 1), and
the remaining 176 were allocated to ei-
ther splinting (89 patients) or surgery
(87 patients). By October 2001, 147 pa-
tients had completed the follow-up as-
sessment 18 months after randomiza-
tion, resulting in a final follow-up rate
of 84%. Reasons for withdrawal are pre-
sented in Figure 1. In both of the groups,
some patients occasionally missed a fol-
low-up assessment, but some of them
completed the questionnaire at home.
TABLE 1 shows the frequency of po-
tential prognostic indicators and the
baseline values of the outcome assess-
ments for each group. There were small
differences between the groups with re-
gard to sex, duration of current epi-
sode of CTS complaints, and patients’
preference for treatment.
Allocated Treatment
All 89 patients allocated to splinting re-
ceived a splint, either custom-made (28
patients [31%]) or prefabricated (61 pa-
tients [68%]), within a median period
of 2 days after randomization (inter-
quartile range, 0-5 days). However, 13
patients (15%) did not receive the treat-
ment according to protocol: 2 received
additional treatment, 1 received phys-
iotherapy, 1 received Mensendieck (ex-
ercise) therapy, and 11 did not wear the
splint every night for at least 6 weeks.
Twenty-four patients (27%) indicated
that they had also worn the splint dur-
ing the day. Eleven patients (12%) used
pain medication during the interven-
tion period.
Of the 87 patients allocated to sur-
gery, 73 (84%) actually underwent this
treatment within a median period of 35
days (interquartile range, 20-55 days) af-
ter randomization. Of the patients who
completed follow-up assessments, 36%
had undergone surgery after 1 month
(29/80), 80% after 3 months (62/78),
and 92% after 6 (71/77), 12 (67/73), and
18 (63/68) months. Of the 14 patients
who did not undergo carpal tunnel sur-
gery, 9 did not receive any treatment and
Table 1. Prognostic Indicators and Baseline Values of Outcomes*
Prognostic Indicator
Surgery
(n = 87)
Splinting
(n = 89)
Age, mean (SD), y 49 (11) 49 (12)
Women, No. (%) 66 (76) 77 (87)
Duration of current episode of CTS complaints,
median (IQR), wk
40 (16-104) 52 (24-104)
Bilateral CTS complaints, No. (%) 48 (55) 56 (63)
Dominant side more severely affected, No. (%) 59 (68) 57 (64)
Previous episodes of CTS complaints, No. (%) 29 (33) 24 (27)
Patients’ preference for treatment, No. (%)
Surgery 22 (25) 29 (33)
Splinting 20 (23) 23 (26)
No preference 46 (53) 37 (42)
Primary Outcomes at Baseline, Median (IQR)†
No. of nights waking up due to symptoms (0-7) 4 (1-7) 4 (1-7)
Severity of the main complaint 7 (6-8) 7 (5-8)
Pain
During day 4 (1-6) 4 (0-6)
During night 5 (0-8) 4 (0-7)
Paresthesia
During day 6 (4-8) 6 (3-8)
During night 6 (2-8) 6 (3-8)
Hypoesthesia
During day 4 (0-7) 3 (0.5-7)
During night 5 (0-8) 5 (0-8)
Secondary Outcomes at Baseline, Median (IQR)†
Symptom severity score (1-5) 2.5 (1.9-3.1) 2.4 (1.8-2.9)
Functional status score (1-5) 2.3 (1.5-3.0) 2.0 (1.5-2.9)
Severity of complaints rated by a research physiotherapist 6 (4-7) 7 (5-7)
Nerve conduction studies, mean (SD), ms
DSL (index finger) (n = 78) (n = 77)
4.2 (1.0) 4.1 (1.0)
Median-ulnar DSL difference (ring finger) (n = 66) (n = 64)
1.7 (1.1) 1.8 (1.4)
DML median nerve (n = 84) (n = 87)
5.6 (1.5) 5.7 (1.9)
*CTS indicates carpal tunnel syndrome; IQR, interquartile range; DSL, distal sensory latency; and DML, distal motor
latency.
†Range of scores is 0-10 (10 indicating severe complaints), unless otherwise indicated. The scores represent the sta-
tus in the previous week, except for symptom severity and functional status scores, which represent the status in the
previous 2 weeks.
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5 were treated differently. Two pa-
tients received physiotherapy, 2 re-
ceived pain medication, and 1 received
a splint. Seven patients (8%) used pain
medication before surgery.
Additional Treatment
In the splint group, 74 (83%) of 89 pa-
tients continued to wear the splint af-
ter the intervention period for a vary-
ing period of time. Furthermore, 52
(58%) of 89 patients received 1 or more
additional treatment options after 6
weeks. Twenty-nine patients received
pain medication, 4 received physio-
therapy, 1 received manual therapy, 2
received Mensendieck (exercise)
therapy, 1 received occupational therapy,
5 received 1 or 2 local corticosteroid in-
jections, and 35 received surgery. Of the
patients who had completed follow-up
assessment, 7% (6/86) received sur-
gery after 3 months, 31% (26/84) after
6 months, 39% (32/83) after 12 months,
and 41% (32/79) after 18 months.
In the surgery group, 26 (30%) of 87
patients received 1 or more additional
treatment options after surgery. Twenty-
five patients received pain medication
primarily to relieve pain caused by the
operation, 2 received physiotherapy, 1
received occupational therapy, and 1 re-
ceived a local corticosteroid injection and
surgery to relieve pain caused by reflex
sympathetic dystrophy.
Treatment Efficacy
Comparisons between the univariate
and multivariate analyses showed that
adjustment for potential prognostic in-
dicators and the baseline values of the
outcome measures minimally influ-
enced the results. Therefore, only the
unadjusted analyses are presented.
Intention-to-Treat Analyses
After 1 month, more patients in the
splint group had improved than in the
surgery group, but more patients in the
surgery group improved after 3, 6, 12,
and 18 months (TABLE 2 and FIGURE 2).
The results of the other outcome mea-
sure assessments are also shown in Table
2 and TABLE 3. Scores for pain and hy-
poesthesia are not presented because the
Figure 2. Success Rates at Each Follow-up Measurement
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Table 2. Success Rates and Improvement in Primary Outcomes After 1, 3, 6, 12, and 18
Months (Intention-to-Treat Analyses)*
Primary Outcome by Month Surgery Splinting Difference† P Value
Success rate, No./total (%)
1 23/80 (29) 37/88 (42) −13 (−28 to 1) .07
3 62/78 (80) 46/86 (54) 26 (12 to 40) .001
6 72/77 (94) 57/84 (68) 26 (14 to 37) .001
12 67/73 (92) 60/83 (72) 20 (8 to 31) .002
18 61/68 (90) 59/79 (75) 15 (3 to 27) .02
No. of nights waking up due
to symptoms, mean (SD)
1 0.8 (3.2) 2.0 (3.0) −1.2 (−2.2 to −0.3) .008
3 2.6 (3.5) 2.2 (3.1) 0.4 (−0.7 to 1.4) .49
6 3.6 (2.8) 2.6 (3.1) 1.0 (0.1 to 2.0) .03
12 3.6 (2.9) 2.9 (3.0) 0.7 (−0.2 to 1.7) .13
18 3.6 (2.9) 3.2 (3.1) 0.4 (−0.6 to 1.4) .44
Severity of the main complaint,
mean (SD)
1 1.6 (2.9) 2.1 (2.2) −0.5 (−1.3 to 0.3) .22
3 5.1 (3.3) 3.2 (2.7) 1.9 (1.0 to 2.8) .001
6 6.6 (2.4) 4.4 (3.2) 2.2 (1.4 to 3.1) .001
12 6.4 (2.7) 5.1 (3.1) 1.3 (0.4 to 2.2) .005
18 6.2 (2.8) 5.0 (3.3) 1.2 (0.2 to 2.3) .02
Paresthesia during the day,
mean (SD)
1 1.5 (3.0) 1.4 (2.1) 0.1 (−0.6 to 1.0) .66
3 4.8 (3.2) 2.2 (3.2) 2.6 (1.6 to 3.6) .001
6 5.5 (2.9) 3.7 (3.2) 1.8 (0.8 to 2.8) .001
12 5.5 (2.9) 4.0 (3.4) 1.5 (0.5 to 2.5) .004
18 5.3 (3.0) 4.0 (3.6) 1.3 (0.3 to 2.5) .01
Paresthesia at night, mean (SD)
1 1.3 (3.1) 2.5 (3.0) −1.2 (−2.1 to −0.2) .02
3 4.6 (3.8) 3.5 (3.3) 1.1 (0 to 2.2) .046
6 5.4 (3.5) 4.1 (3.7) 1.3 (0.2 to 2.4) .02
12 5.2 (3.6) 4.5 (3.4) 0.7 (−0.4 to 1.8) .20
18 5.0 (3.6) 4.4 (3.6) 0.6 (−0.6 to 1.7) .35
*Patient cohorts are presented in Figure 1. The values are expressed as the mean (SD) improvements from baseline
unless otherwise indicated.
†Indicates the differences (surgery minus splint) in success rates and in the mean improvements from baseline (95%
confidence interval).
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findings were similar to those for par-
esthesia. After 1 month, the differences
in the primary outcome measures were
mainly in favor of splinting. However,
after 3, 6, 12, and 18 months, surgery
was found to be more effective than
splinting and with regard to the second-
ary outcomes. There was no difference
in outcomes between patients in the
splint group using a custom-made splint
and those using a prefabricated splint.
An additional analysis was per-
formed for the outcome measure suc-
cess rate, using last observation car-
ried forward for the patients who
withdrew from the study. When this
was done for the 10 patients who with-
drew from the splint group, the suc-
cess rates for this group were 52% (46/
89) after 3 months, 66% (59/89) after
6 months, 71% (63/89) after 12 months,
and 72% (64/89) after 18 months. Four
patients in the surgery group did not
have any of the follow-up assessments
taken and were regarded as not im-
proved. In addition, in the analysis us-
ing the last observation carried for-
ward for the other 15 patients who
withdrew from the surgery group, the
success rates were 26% (23/87) after 1
month, 74% (64/87) after 3 months,
87% (76/87) after 6 months, 86% (75/
87) after 12 months, and 85% (74/87)
after 18 months.
Withdrawal was not related to gen-
eral improvement.Of the10patientswho
withdrew from the splint group, 5 indi-
cated to be much improved at the time
of withdrawal, 2 indicated to be slightly
improved,1 indicatedthatnochangehad
occurred,1 indicatedtobeslightlyworse,
and1 indicated tobemuchworse.Of the
19 patients who withdrew from the sur-
gery group, 4 did not have any fol-
low-up assessments, 10 indicated to be
completely recoveredat the timeofwith-
drawal,3 indicatedtobemuchimproved,
1 indicated to be slightly improved, and
1 indicated no change.
In the first additional analysis, pa-
tients who received surgery after splint-
ing were considered to be “not im-
proved.” After 18 months, only 29 of
79 patients indicated to be improved by
splinting alone, resulting in a final suc-
cess rate of 37% for the splint group.
In the second additional analysis, pa-
tients in the splint group who had re-
ceived surgery were compared with pa-
tients in the same group who had not.
After 18 months, the success rate in the
group of patients who received sur-
gery after splinting was 94% (30/32
patients) compared with 62% (29/47
patients) in the group who did not un-
dergo surgical treatment. Also with
regard to the other primary outcomes,
the patients in the splint group who
received surgery showed statistically
significant more improvement after 18
months than the patients who did not
have surgery.
Adverse Effects
TABLE 4 shows the frequency of ad-
verse effects reported by the patients in
each group during the 18 months of fol-
low-up. Although many patients re-
ported adverse effects, most of these
were relatively mild and of short dura-
tion. However, 1 patient in the sur-
gery group developed reflex sympa-
thetic dystrophy.
Success of Blinding
The physiotherapists correctly indi-
cated the treatment received 85% (139/
164) of the time after 3 months, 71%
(114/161) after 6 months, and 65% (101/
156) after 12 months. Many patients in-
advertently mentioned their treatment,
Table 3. Improvement in Secondary Outcomes After 3, 6, 12, and 18 Months
(Intention-to-Treat Analyses)*
Secondary Outcome by Month Surgery Splinting Difference† P Value
Symptom severity score
3 1.0 (0.9) 0.6 (0.7) 0.4 (0.2 to 0.7) .001
6 1.3 (0.8) 0.9 (0.8) 0.4 (0.2 to 0.7) .001
12 1.3 (0.8) 0.9 (0.9) 0.4 (0.1 to 0.7) .003
18 1.3 (0.8) 0.9 (0.9) 0.4 (0.1 to 0.6) .02
Functional status score
3 0.6 (0.9) 0.4 (0.7) 0.2 (0 to 0.5) .07
6 1.0 (0.9) 0.5 (0.8) 0.5 (0.2 to 0.7) .001
12 1.0 (0.9) 0.7 (0.8) 0.3 (0 to 0.6) .03
18 0.9 (0.9) 0.7 (0.8) 0.2 (−0.1 to 0.5) .12
Severity of complaints rated by a
research physiotherapist, mo
3 (n = 69) (n = 80)
3.5 (3.4) 2.2 (2.6) 1.3 (0.4 to 2.4) .007
6 (n = 70) (n = 76)
5.4 (2.5) 3.3 (2.7) 2.1 (1.2 to 2.9) .001
12 (n = 67) (n = 77)
5.3 (3.0) 3.7 (3.0) 1.6 (0.6 to 2.6) .002
Nerve conduction studies at 12 mo, ms
Distal sensory latency (index finger) (n = 56) (n = 59)
1.0 (1.0) 0.7 (0.8) 0.3 (0 to 0.7) .04
Median-ulner distal sensory latency (n = 48) (n = 50)
difference (ring finger) 1.1 (1.2) 0.7 (1.2) 0.4 (0 to 0.9) .07
Distal motor latency median nerve (n = 63) (n = 70)
1.3 (1.5) 1.0 (1.5) 0.3 (−0.2 to 0.8) .25
*Patient cohorts are presented in Figure 1. The values are expressed as the mean (SD) improvements from baseline
unless otherwise indicated.
†Indicates the differences (surgery minus splint) in success rates and in the mean improvements from baseline (95%
confidence interval).
Table 4. Adverse Effects Reported by the
Patients During the Follow-up Period of 18
Months
No. of Patients Who
Reported
Surgery
(n = 87)
Splinting
(n = 89)
Adverse effects, No. (%) 58 (67) 46 (52)
Painful or hypertrophic
scar
53 20
Stiffness of the wrist,
hand, or fingers
24 31
Skin irritation 19 8
Wound hematoma 10 1
Wound infection 5 2
Discomfort caused by
pressure of the
splint
0 6
Swelling of the wrist,
hand, or fingers
0 4
Severe pillar pain 2 0
Reflex sympathetic
dystrophy
1 0
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and guesses were often based on the
course of symptoms during the fol-
low-up period and on the way patients
reacted to the physical examinations.
COMMENT
This RCT compared the short-term and
long-term efficacy of surgery and splint-
ing for relieving the symptoms of CTS.
Although only 176 patients were in-
cluded, instead of the 190 originally
planned, this did not reduce the power
of the trial because the differences be-
tween the groups were large enough to
be detected. Furthermore, although
many outcomes were analyzed at dif-
ferent follow-up times, the results are
not likely to be due to chance, as they
all are in the same direction.
The results of the intention-to-treat
analyses showed that surgery was more
effective than splinting after 3, 6, 12, and
18 months. These differences became
smaller after 12 months, probably be-
cause a large proportion of patients in
the splint group received additional sur-
gery. The differences after 1 month were
mainly in favor of splinting, which might
have resulted from patients allocated to
splinting having started their treat-
ment almost immediately after random-
ization, in contrast to patients in the sur-
gery group. Randomization was chosen
as the reference point for the timing of
the follow-up assessments, and not the
actual start of the treatment because in-
cluding the time waiting to undergo sur-
gery reflects current clinical practice.
However, as the median time to un-
dergo surgery was 35 days, taking the
actual start of the treatment as a refer-
ence point would result in a shift to the
left (of 1 month) of the line of the sur-
gery group in Figure 2.
We believe the results of this trial are
applicable to most patients with clini-
cally and electrophysiologically con-
firmed idiopathic CTS. However, the
least severe and the most severe cases
were probably not included in this trial.
These patients (or physicians) typi-
cally have a strong preference for splint-
ing or surgery.
This trial was mainly based on sub-
jective, patient-reported outcomes be-
cause the perspective of the patient was
considered to be the most important.
As blinding of the patients for the al-
located treatment was not possible, the
results could be biased because pa-
tients tend to report greater effects from
their preferred method of treatment.16
However, subgroup analyses showed
that treatment effects did not depend
on the patients’ preference prior to ran-
domization (data not shown). An at-
tempt was made to include a more ob-
jective evaluation of outcome by
involving blinded research physiothera-
pists who scored the overall severity of
CTS complaints. However, blinding of
the research physiotherapists was not
successful in most cases.
Treatment success was defined a
priori as “completely recovered” or
“much improved.” When analyzing the
data, it was found that most of the suc-
cesses in the surgery group were “com-
pletely recovered,” while patients in the
splint group were only “much im-
proved.” Thus, if success was solely de-
fined as “completely recovered,” the dif-
ferences between the groups would
have been even more pronounced.
The American Academy of Neurol-
ogy recommends treatment of CTS with
noninvasive options (eg, wrist splints)
first, and open carpal tunnel release only
if noninvasive treatment proves to be in-
effective.17 This RCT showed that treat-
ment of CTS with surgery results in bet-
ter outcomes. A splint might be used
while a patient waits for surgery be-
cause the waiting period for open car-
pal tunnel release in practice is often
longer than in this study, as efforts were
made to make an appointment for the pa-
tients within 4 weeks after randomiza-
tion. Patients not willing to undergo sur-
gery could also be offered a splint.
Another recently conducted RCT found
that patients wearing a wrist splint
showed more relief from symptoms than
patients not receiving any treatment.18
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